Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fulcrum Therapeutics Inc (FULC)

Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fulcrum Therapeutics Inc 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 USA

www.fulcrumtx.com P: 617-651-8851

Description:

Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum Therapeutics Inc. is based in Cambridge, United States.

Key Statistics

Overview:

Market Capitalization, $K 452,481
Enterprise Value, $K 426,921
Shares Outstanding, K 62,154
Annual Sales, $ 2,810 K
Annual Net Income, $ -97,340 K
Last Quarter Sales, $ 870 K
Last Quarter Net Income, $ -24,760 K
EBIT, $ -110,660 K
EBITDA, $ -108,490 K
60-Month Beta 2.29
% of Insider Shareholders 2.50%
% of Institutional Shareholders 89.83%
Float, K 60,600
% Float 97.50%
Short Volume Ratio 0.47

Growth:

1-Year Return 175.13%
3-Year Return -35.29%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.40 on 02/27/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -1.58
EPS Growth vs. Prev Qtr -2.56%
EPS Growth vs. Prev Year 20.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

FULC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -36.65%
Return-on-Assets % -33.62%
Profit Margin % -3,464.06%
Debt/Equity 0.00
Price/Sales 164.86
Price/Cash Flow N/A
Price/Book 1.91
Book Value/Share 3.80
Interest Coverage -1.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar